KEGG   Sarcophilus harrisii (Tasmanian devil): 100929676
Entry
100929676         CDS       T02286                                 
Symbol
BID
Name
(RefSeq) BH3-interacting domain death agonist
  KO
K04726  BH3 interacting domain death agonist
Organism
shr  Sarcophilus harrisii (Tasmanian devil)
Pathway
shr01524  Platinum drug resistance
shr04071  Sphingolipid signaling pathway
shr04115  p53 signaling pathway
shr04210  Apoptosis
shr04215  Apoptosis - multiple species
shr04217  Necroptosis
shr04650  Natural killer cell mediated cytotoxicity
shr04932  Non-alcoholic fatty liver disease
shr05010  Alzheimer disease
shr05014  Amyotrophic lateral sclerosis
shr05022  Pathways of neurodegeneration - multiple diseases
shr05152  Tuberculosis
shr05160  Hepatitis C
shr05161  Hepatitis B
shr05162  Measles
shr05163  Human cytomegalovirus infection
shr05164  Influenza A
shr05167  Kaposi sarcoma-associated herpesvirus infection
shr05168  Herpes simplex virus 1 infection
shr05169  Epstein-Barr virus infection
shr05170  Human immunodeficiency virus 1 infection
shr05200  Pathways in cancer
shr05416  Viral myocarditis
shr05417  Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:shr00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04071 Sphingolipid signaling pathway
    100929676 (BID)
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    100929676 (BID)
   04215 Apoptosis - multiple species
    100929676 (BID)
   04217 Necroptosis
    100929676 (BID)
   04115 p53 signaling pathway
    100929676 (BID)
 09150 Organismal Systems
  09151 Immune system
   04650 Natural killer cell mediated cytotoxicity
    100929676 (BID)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    100929676 (BID)
  09172 Infectious disease: viral
   05170 Human immunodeficiency virus 1 infection
    100929676 (BID)
   05161 Hepatitis B
    100929676 (BID)
   05160 Hepatitis C
    100929676 (BID)
   05164 Influenza A
    100929676 (BID)
   05162 Measles
    100929676 (BID)
   05168 Herpes simplex virus 1 infection
    100929676 (BID)
   05163 Human cytomegalovirus infection
    100929676 (BID)
   05167 Kaposi sarcoma-associated herpesvirus infection
    100929676 (BID)
   05169 Epstein-Barr virus infection
    100929676 (BID)
  09171 Infectious disease: bacterial
   05152 Tuberculosis
    100929676 (BID)
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    100929676 (BID)
   05014 Amyotrophic lateral sclerosis
    100929676 (BID)
   05022 Pathways of neurodegeneration - multiple diseases
    100929676 (BID)
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    100929676 (BID)
   05416 Viral myocarditis
    100929676 (BID)
  09167 Endocrine and metabolic disease
   04932 Non-alcoholic fatty liver disease
    100929676 (BID)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    100929676 (BID)
SSDB
Motif
Pfam: BID Bcl-2
Other DBs
NCBI-GeneID: 100929676
NCBI-ProteinID: XP_012406282
Ensembl: ENSSHAG00000009324
UniProt: G3W5W2
LinkDB
Position
5:complement(64129598..64173057)
AA seq 188 aa
MDQDNRQTSLLLYNFLQSSGNNLFQTELKELDSELAVFGSRNGCSEQDYELQTDGNRCYF
DMSREEFSDSENQEIIQRIATHLAQIGDNIESSIQPSLVDNLIQQFRIINLSAEDKRRYL
DAAMQQMMQTIPLDLEQEKAQLLLAMLLAKKVMTHAPSLFRSIFYITVDYMNQNLITYIR
NLVRNDMD
NT seq 567 nt   +upstreamnt  +downstreamnt
atggatcaggataatagacagaccagtttgctgctgtacaacttcctacaaagttccggt
aacaaccttttccaaacggagctaaaggagctggacagtgagctggctgtgtttggctcc
aggaatggctgttcggagcaggactatgagctgcaaacagatggcaatcggtgctatttt
gacatgtccagagaggagttctcagattcagaaaaccaagaaattatccagcgcatagcg
acacaccttgcccagatcggggacaatatagagagtagcatccagcccagcttggtggat
aacctgatccagcagttcagaattattaatctgtcagctgaggacaagaggagatacctg
gatgctgctatgcaacaaatgatgcaaacaattcctctggatcttgagcaagagaaggct
caattattgctagcaatgctgttggctaaaaaagttatgacccatgccccatccttgttc
cgaagcatcttttatatcaccgtagattacatgaatcagaacctcattacctacataagg
aacttggtcagaaatgatatggactga

DBGET integrated database retrieval system